OtherArchives of rehabilitation research and clinical translation2026

Resistance Exercise as a Dual-Target Strategy in Physical Therapy: Reducing Depressive Symptoms to Improve Rehabilitation Participation and Outcomes.

Volodymyr Maksym

PMID 42326567

WHAT IT FOUND

An argument, not a trial.

The authors propose that resistance exercise in physical therapy can be deliberately framed to target mood, self-efficacy and engagement alongside strength, and set out delivery principles and example doses. No patients were studied and no outcomes reported.

What this paper is

This is a Special Communication: a conceptual proposal arguing that resistance exercise delivered in physical therapy can be framed to support functional recovery and mood-related engagement at the same time. It reports no patients, no trial and no outcome data. What it contains is the authors' reasoning, a set of practical delivery principles, three illustrative dosing examples, and a mapping table linking resistance exercise features to mood-related mediators and rehabilitation outcomes. The authors describe that table as evidence-informed conceptual mapping rather than a causal estimate. There is no result here to change your practice on.

The easy way to misread this

Do not read the dosing examples or the mapping table as tested protocols. This paper ran no study and reports no outcomes of its own. The authors state plainly that the table is a conceptual mapping and not a causal estimate, and the evidence they cite for resistance exercise reducing depressive symptoms comes from other people's meta-analyses, not from work done here.

Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →


The study

Certainty of evidence
Low

Browse

    Cite

    Volodymyr Maksym Resistance Exercise as a Dual-Target Strategy in Physical Therapy: Reducing Depressive Symptoms to Improve Rehabilitation Participation and Outcomes. Archives of rehabilitation research and clinical translation. 2026.

    Read the original — we summarise, we never replace the paper.